Skip to main content

U.S. Pharmaceutical Sales - Q3 2011

The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2011. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 drugs for Q3 2011 by units sold

Rank Drug Units (000)
1 acetaminophen/hydrocodone
Generic
-2.04% Stats
2 (2) budesonide
Generic
25.08% Stats
3 (3) ProAir HFA
Teva Pharmaceuticals USA, Inc.
4.51% Stats
4 (2) Nexium
AstraZeneca
-4.78% Stats
5 OneTouch
-2.58% Stats
6 (3) Singulair
Merck
-10.40% Stats
7 Lipitor
-3.00% Stats
8 (1) Lantus
Sanofi
-1.70% Stats
9 (1) Cymbalta
-1.53% Stats
10 (2) Advair Diskus
GlaxoSmithKline
-6.71% Stats
11 Plavix
-2.58% Stats
12 fentanyl
Generic
-2.50% Stats
13 AndroGel
AbbVie Inc.
-8.93% Stats
14 Crestor
AstraZeneca
-0.46% Stats
15 (3) Lantus Solostar
Sanofi
6.00% Stats
16 (1) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
-2.45% Stats
17 (2) Novolog
Novo Nordisk
-2.66% Stats
18 (1) Actos
Takeda Pharmaceutical Company Limited
-12.03% Stats
19 (4) Synthroid
AbbVie Inc.
6.60% Stats
20 (1) Humalog
Eli Lilly and Company
-1.78% Stats
21 (1) Abilify
Otsuka Pharmaceutical Co., Ltd
-2.54% Stats
22 (2) Nasonex
Merck
-16.18% Stats
23 (2) Levemir
Novo Nordisk
4.10% Stats
24 metoprolol
Generic
-5.94% Stats
25 (1) Lexapro
Allergan plc
-5.92% Stats
26 (1) Diovan
Novartis Pharmaceuticals Corporation
-8.44% Stats
27 (8) NovoLog FlexPen
Novo Nordisk
4.92% Stats
28 (4) Januvia
Merck
0.79% Stats
29 (1) Namenda
Allergan plc
-2.27% Stats
30 (1) Lyrica
-2.10% Stats
31 (2) Combivent
Boehringer Ingelheim Pharmaceuticals, Inc.
-6.36% Stats
32 (1) Zetia
Merck
-4.00% Stats
33 (6) Suboxone
3.23% Stats
34 (2) Seroquel
AstraZeneca
-5.73% Stats
35 (2) Flovent HFA
GlaxoSmithKline
-9.36% Stats
36 (9) enoxaparin
Generic
4.41% Stats
37 (6) Lidoderm
Endo Pharmaceuticals Inc.
-1.63% Stats
38 (6) Remicade
Janssen Pharmaceuticals, Inc.
1.03% Stats
39 (1) Lovaza
GlaxoSmithKline
-8.75% Stats
40 () Fluvirin
Seqirus
n/a Stats
41 Vytorin
Merck
-10.72% Stats
42 Benicar
Daiichi Sankyo
-5.85% Stats
43 (3) Symbicort
AstraZeneca
0.27% Stats
44 (3) Zyprexa
-7.60% Stats
45 (3) Diovan HCT
Novartis Pharmaceuticals Corporation
-7.76% Stats
46 (3) OxyContin
Purdue Pharma LP
-4.69% Stats
47 (3) Restasis
Allergan plc
-1.16% Stats
48 (4) Lovenox
Sanofi
-7.70% Stats
49 (2) Niaspan
AbbVie Inc.
-10.46% Stats
50 (3) Celebrex
-4.32% Stats
51 (3) TriCor
AbbVie Inc.
-4.39% Stats
52 (4) VESIcare
Astellas Pharma US, Inc.
-0.84% Stats
53 (2) Evista
-4.25% Stats
54 (6) Janumet
Merck
1.52% Stats
55 (3) Enbrel
Amgen Inc.
-2.97% Stats
56 (1) Aciphex
Eisai Inc.
-10.77% Stats
57 () Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
n/a Stats
58 (4) Geodon
-3.65% Stats
59 (4) Vyvanse
Takeda Pharmaceutical Company Limited
1.51% Stats
60 (1) Epogen
Amgen Inc.
-18.41% Stats
61 (3) Rebif
EMD Serono, Inc.
-1.49% Stats
62 (15) methylphenidate
Generic
40.86% Stats
63 (2) amphetamine/dextroamphetamine
Generic
2.25% Stats
64 (2) Cialis
Eli Lilly and Company
2.01% Stats
65 (4) Humira
AbbVie Inc.
3.01% Stats
66 (2) Truvada
Gilead Sciences, Inc.
1.69% Stats
67 Rituxan
Genentech, Inc.
-1.86% Stats
68 (2) Provigil
1.16% Stats
69 (6) Atripla
Gilead Sciences, Inc.
0.88% Stats
70 (2) Avastin
Genentech, Inc.
-3.61% Stats
71 (3) Seroquel XR
AstraZeneca
-1.96% Stats
72 (1) Viagra
-3.64% Stats
73 (10) Varivax
Merck
42.81% Stats
74 (2) Adderall XR
Takeda Pharmaceutical Company Limited
-10.30% Stats
75 (4) Lunesta
Sunovion Pharmaceuticals Inc.
-2.39% Stats
76 (4) Aranesp
Amgen Inc.
-11.29% Stats
77 (5) Neulasta
Amgen Inc.
-5.69% Stats
78 (7) Solodyn
Medicis Pharmaceutical Corporation
16.10% Stats
79 (1) Procrit
Janssen Pharmaceuticals, Inc.
-21.32% Stats
80 (6) docetaxel
Generic
6.02% Stats
81 (3) Reyataz
Bristol-Myers Squibb Company
-1.75% Stats
82 (5) Erbitux
Eli Lilly and Company
-1.93% Stats
83 (9) Eloxatin
Sanofi
29.67% Stats
84 (4) Lucentis
Genentech, Inc.
0.87% Stats
85 (4) Copaxone
Teva Pharmaceuticals USA, Inc.
-0.44% Stats
86 (4) Isentress
Merck
2.74% Stats
87 () Opana ER
Endo Pharmaceuticals Inc.
n/a Stats
88 (3) Zometa
Novartis Pharmaceuticals Corporation
-4.78% Stats
89 () Prezista
Janssen Pharmaceuticals, Inc.
n/a Stats
90 () Prevnar 13
Pfizer Inc.
n/a Stats
91 (2) Alimta
Eli Lilly and Company
-0.59% Stats
92 (2) Neupogen
Amgen Inc.
0.64% Stats
93 (3) Herceptin
Genentech, Inc.
-0.67% Stats
94 (1) Zyvox
Pfizer Inc.
-9.68% Stats
95 (2) Avonex
Biogen
-1.43% Stats
96 (2) Velcade
Takeda Pharmaceutical Company Limited
1.49% Stats
97 (2) Gleevec
Novartis Pharmaceuticals Corporation
-2.35% Stats
98 (2) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
-2.47% Stats
99 () Xeloda
Genentech, Inc.
n/a Stats
100 () Incivek
Vertex Pharmaceuticals Incorporated
n/a Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.